Prospective study of lidocaine, bupivacaine, and epinephrine levels and blood loss in patients undergoing liposuction and abdominoplasty

Plastic and Reconstructive Surgery

Volumn 130, Issue 3, 2012, Pages 702-722

  Swanson, Eric ^a  

^a Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPIVACAINE; LIDOCAINE;

ABDOMINOPLASTY; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; FEMALE; HUMAN; LIPECTOMY; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; STATISTICS;

ABDOMINOPLASTY; ADULT; ANALYSIS OF VARIANCE; BUPIVACAINE; EPINEPHRINE; FEMALE; HUMANS; LIDOCAINE; LIPECTOMY; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES;

EID: 84866005591     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31825dc408     Document Type: Article

References (89)

1. Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol. 1990;16:248-263.
2. Hetter GP. The effect of low dose epinephrine on the hematocrit drop following lipolysis. Aesthetic Plast Surg. 1984;8: 19-21.
3. Maimon WN, Schuller DE. Lidocaine v bupivacaine in facial plastic surgery: A clinical trial. Arch Otolaryngol. 1984;110: 525-528.
4. Iverson RE, Lynch DJ; American Society of Plastic Surgeons Committee on Patient Safety. Practice advisory on liposuction. Plast Reconstr Surg. 2004;113:1478-1490.
5. Haeck PC, Swanson JA, Gutowski KA, et al. Evidence-based patient safety advisory: Liposuction. Plast Reconstr Surg. 2009; 124(Suppl):28S-44S.
6. Mustoe TA, BuckDWII, Lalonde DH. The safe management of anesthesia, sedation, and pain in plastic surgery. Plast Reconstr Surg. 2010;126:165e-176e.
7. Burk RW III, Guzman-Stein G, Vasconez LO. Lidocaine and epinephrine levels in tumescent technique liposuction. Plast Reconstr Surg. 1996;97:1379-1384.
8. Brown SA, Lipschitz AH, Kenkel JM, et al. Pharmacokinetics and safety of epinephrine use in liposuction. Plast Reconstr Surg. 2004;114:756-763; discussion 764-765.
9. Swanson E. Prospective clinical study reveals significant reduction in triglyceride level and white blood cell count after liposuction and abdominoplasty and no change in cholesterol levels. Plast Reconstr Surg. 2011;128:182e-197e.
10. Pitman GH, Aker JS, Tripp ZD. Tumescent liposuction: A surgeon's perspective. Clin Plast Surg. 1996;23:633-641; discussion 642-645.
11. Gross JB. Estimating allowable blood loss: Corrected for dilution. Anesthesiology 1983;58:277-280.
12. Matarasso A. Lidocaine in ultrasound-assisted lipoplasty. Clin Plast Surg. 1999;26:431-439.
13. Grazer FM. Quantitative analysis of blood and fat in suction lipectomy aspirates (Discussion). Plast Reconstr Surg. 1986; 78:770-772.
14. Ostad A, Kageyama N, Moy RL. Tumescent anesthesia with lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol Surg. 1996;22:921-927.
15. Fodor PB, Watson J. Personal experience with ultrasoundassisted lipoplasty: A pilot study comparing ultrasound-assisted lipoplasty with traditional lipoplasty. Plast Reconstr Surg. 1998;101:1103-1116; discussion 1117-1119.
16. Samdal F, Amland PF, Bugge JF. Plasma lidocaine levels during suction-assisted lipectomy using large doses of dilute lidocaine with epinephrine. Plast Reconstr Surg. 1994;93: 1217-1223.
17. Hatef DA, Brown SA, Lipschitz AH, Kenkel JM. Efficacy of lidocaine for pain control in subcutaneous infiltration during liposuction. Aesthet Surg J. 2009;29:122-128.
18. Rubin JP, Bierman C, Rosow CE, et al. The tumescent technique: The effect of high tissue pressure and dilute epinephrine on absorption of lidocaine. Plast Reconstr Surg. 1999; 103:990-996; discussion 997-1002.
19. Kenkel JM, Lipschitz AH, Shepherd G, et al. Pharmacokinetics and safety of lidocaine and monoethylglycinexylidide in liposuction: A microdialysis study. Plast Reconstr Surg. 2004; 114:516-524; discussion 525-526.
20. Jones BM, Grover R. Reducing complications in cervicofacial rhytidectomy by tumescent infiltration: A comparative trial evaluating 678 consecutive face lifts. Plast Reconstr Surg. 2004; 113:398-403.
21. Mottura AA. Local infiltrative anesthesia for transaxillary subpectoral breast implants. Aesthetic Plast Surg. 1995;19: 37-39.
22. Kazmier FR, Henry SL, Christiansen D, Puckett CL. A prospective, randomized, double-blind controlled trial of continuous local anesthetic infusion in cosmetic breast augmentation. Plast Reconstr Surg. 2008;121:711-715.
23. McCarthy CM, Pusic AL, Hidalgo DA. Efficacy of pocket irrigation with bupivacaine and ketorolac in breast augmentation: A randomized controlled trial. Ann Plast Surg. 2009; 62:15-17.
24. Zukowski ML, Ash K, Klink B, Reid D, Messa A. Breast reduction under intravenous sedation: A review of 50 cases. Plast Reconstr Surg. 1996;97:952-956; discussion 957-958.
25. Heller L, Kowalski AM, Wei C, Butler CE. Prospective, randomized double-blind trial of local anesthetic infusion and intravenous narcotic patient-controlled anesthesia pump for pain management after free TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;122:1010-1018.
26. Gilliland MD, Commons GW, Halperin B. Safety issues in ultrasound-assisted large-volume lipoplasty. Clin Plast Surg. 1999;26:317-335.
27. Fodor PB, Watson JP. Wetting solutions in ultrasound-assisted lipoplasty. Clin Plast Surg. 1999;26:289-293.
28. Commons GW, Halperin B, Chang CC. Large-volume liposuction: A review of 631 cases over 12 years. Plast Reconstr Surg. 2001;108:1753-1763; discussion 1764-1767.
29. Failey CL, Vemula R, Borah GL, Hsia HC. Intraoperative use of bupivacaine for tumescent liposuction: The Robert Wood Johnson experience. Plast Reconstr Surg. 2009;124:1304-1311.
30. Mottura AA. Local anesthesia for abdominoplasty, liposuction, and combined operations. Aesthetic Plast Surg. 1993;17: 117-124.
31. Abramson DL. Tumescent abdominoplasty: An ambulatory office procedure. Aesthetic Plast Surg. 1998;22:404-407.
32. Spiegelman JI, Levine RH. Abdominoplasty: A comparison of outpatient and inpatient procedures shows that it is a safe and effective procedure for outpatients in an office-based surgery clinic. Plast Reconstr Surg. 2006;118:517-522; discussion 523-524.
33. Michaels BM, Eko FN. Outpatient abdominoplasty facilitated by rib blocks. Plast Reconstr Surg. 2009;124:635-642.
34. Feng LJ. Painless abdominoplasty: The efficacy of combined intercostal and pararectus blocks in reducing postoperative pain and recovery time. Plast Reconstr Surg. 2010;126:1723-1732; discussion 1733-1734.
35. Shiffman MA. The future of liposuction and fat. Plast Reconstr Surg. 2000;106:505-507.
36. Klein JA. Intravenous fluids and bupivacaine are contraindicated in tumescent liposuction. Plast Reconstr Surg. 1998; 102:2516-2519.
37. Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979;51:285-287.
38. Katz RL. Intravenous fluids and bupivacaine are contraindicated in tumescent liposuction. Plast Reconstr Surg. 1998;102: 2516-2519.
39. Drugs.com (Web site). Bupivacaine. Available at: http://www.drugs.com/ pro/bupivacaine.html. Accessed May 21, 2011.
40. Rosenblatt MA, Abel M, Fischer G, Itzkovitch CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006;105:217-218.
41. Rao RB, Ely SF, Hoffman RS. Deaths related to liposuction. N Engl J Med. 1999;340:1471-1475.
42. Tuominen M, Rosenberg PH, Kalso E. Blood levels of bupivacaine after single dose, supplementary dose and during continuous infusion in axillary plexus block. Acta Anaesthesiol Scand. 1983;27:303-306.
43. Samdal F, Amland PF, Bugge JF. Blood loss during liposuction using the tumescent technique. Aesthetic Plast Surg. 1994; 18:157-160.
44. Scarborough DA, Herron JB, Khan A, Bisaccia E. Experience with more than 5,000 cases in which monitored anesthesia care was used for liposuction surgery. Aesthetic Plast Surg. 2004;27:474-480.
45. Rohrich RJ, Beran SJ, Fodor PB. The role of subcutaneous infiltration in suction-assisted lipoplasty: A review. Plast Reconstr Surg. 1997;99:514-519; discussion 520-526.
46. Thomson CJ, Lalonde DH. Randomized double-blind comparison of duration of anesthesia among three commonly used agents in digital nerve block. Plast Reconstr Surg. 2006; 118:429-432.
47. Kryger ZB, Fine NA, Mustoe TA. The outcome of abdominoplasty performed under conscious sedation: Six-year experience in 153 consecutive cases. Plast Reconstr Surg. 2004; 113:1807-1817; discussion 1818-1819.
48. Kenkel JM, Lipschitz AH, Luby M, et al. Hemodynamic physiology and thermoregulation in liposuction. Plast Reconstr Surg. 2004;114:503-513; discussion 514-515.
49. Dunlevy TM, O'Malley TP, Postma GN. Optimal concentration of epinephrine for vasoconstriction in neck surgery. Laryngoscope 1996;106:1412-1414.
50. Byun MY, Fine NA, Lee JY, Mustoe TA. The clinical outcome of abdominoplasty performed under conscious sedation: Increased use of fentanyl correlated with longer stay in outpatient unit. Plast Reconstr Surg. 1999;103:1260-1266.
51. Mustoe TA. Abdominoplasty: A comparison of outpatient and inpatient procedures shows that it is a safe and effective procedure for outpatients in an office-based surgery clinic (Discussion). Plast Reconstr Surg. 2006;118:523-524.
52. Ersek RA. Fatal pulmonary embolism (Letter). Plast Reconstr Surg. 2004;113:1868.
53. Friedberg BL. Lethal pulmonary embolisms are avoidable. Plast Reconstr Surg. 2009;123:768; author reply 768-769.
54. Gurunluoglu R, Swanson JA, Haeck PC; the ASPS Patient Safety Committee . Evidence-based patient safety advisory: Malignant hyperthermia. Plast Reconstr Surg. 2009;124(Suppl): 68S-81S.
55. Hatef DA, Kenkel JM, Nguyen M, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008; 122:269-279.
56. Buck DW II, Mustoe TA. An evidence-based approach to abdominoplasty. Plast Reconstr Surg. 2010;126:2189-2195.
57. Matarasso A. Abdominolipoplasty. Clin Plast Surg. 1989;16: 289-303.
58. Trott SA, Beran SJ, Rohrich RJ, Kenkel JM, Adams WP Jr, Klein KW. Safety considerations and fluid resuscitation in liposuction: An analysis of 53 consecutive patients. Plast Reconstr Surg. 1998;102:2220-2229.
59. Cárdenas-Camarena L, Tobar-Losada A, Lacouture AM. Large-volume circumferential liposuction with tumescent technique: A sure and viable procedure. Plast Reconstr Surg. 1999;104:1887-1899.
60. Cárdenas-Camarena L, González LE. Large-volume liposuction and extensive abdominoplasty: A feasible alternative for improving body shape. Plast Reconstr Surg. 1998;102:1698-1707.
61. Hunstad JP, Aitken ME. Liposuction and tumescent surgery. Clin Plast Surg. 2006;33:39-46.
62. Gilliland MD, Coates N. Tumescent liposuction complicated by pulmonary edema. Plast Reconstr Surg. 1997;99:215-219.
63. Fodor PB. Wetting solutions in aspirative lipoplasty: A plea for safety in liposuction. Aesthetic Plast Surg. 1995;19:379-380.
64. Liu AS, Nargozian C, Greene AK. Subcutaneous epinephrine for vasoconstriction: An evidence-based evaluation. Plast Reconstr Surg. 2010;126:157e-158e.
65. O'Malley TP, Postma GN, Holtel M, Girod DA. Effect of local epinephrine on cutaneous bloodflow in the human neck. Laryngoscope 1995;105:140-143.
66. Clutter WE, Bier DM, Shah SD, Cryer PE. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 1980;66:94-101.
67. Butterwick KJ, Goldman MP, Sriprachya-Anunt S. Lidocaine levels during the first two hours of infiltration of dilute anesthetic solution for tumescent liposuction: Rapid versus slow delivery. Dermatol Surg. 1999;25:681-685.
68. Chapin JC, Kushins LG, Munson ES, Schick LM. Lidocaine, bupivacaine, etidocaine, and epinephrine-induced arrhythmias during halothane anesthesia in dogs. Anesthesiology 1980;52:23-26.
69. Kulier AH, Woehlck HJ, Hogan QH, et al. Epinephrine dysrhythmogenicity is not enhanced by subtoxic bupivacaine in dogs. Anesth Analg. 1996;83:62-67.
70. Rubinstein EH. An anesthesiologist's perspective of lipoplasty. Clin Plast Surg. 1999;26:423-429.
71. Kenkel JM, Brown SA, Love EJ, et al. Hemodynamics, electrolytes, and organ histology of larger-volume liposuction in a porcine model. Plast Reconstr Surg. 2004;113:1391-1399.
72. Lipschitz AH, Kenkel JM, Luby M, Sorokin E, Rohrich RJ, Brown SA. Electrolyte and plasma enzyme analyses during large-volume liposuction. Plast Reconstr Surg. 2004;114:766-775; discussion 776-777.
73. Liposuction.com (Web site). Tumescent liposuction. Available at: http://www.liposuction.com/lipo-techniques/about-tumescent.php. Accessed May 21, 2011.
74. Rohrich RJ, Kenkel JM, Janis JE, Beran SJ, Fodor FB. An update on the role of subcutaneous infiltration in suctionassisted lipoplasty. Plast Reconstr Surg. 2003;111:926-927; discussion 928.
75. Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with large-volume liposuction: A pilot study. Plast Reconstr Surg. 2001;108: 510-519; discussion 520-521.
76. Goodpasture JC, Bunkis J. Quantitative analysis of blood and fat in suction lipectomy aspirates. Plast Reconstr Surg. 1986; 78:765-772.
77. Hetter GP, Herhahn F. Experience with "lipolysis": The Illouz technique of blunt suction lipectomy in North America. Aesthetic Plast Surg. 1983;7:69-76.
78. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology 2008;109:723-740.
79. Rohrich RJ, Beran SJ. Is liposuction safe? Plast Reconstr Surg. 1999;104:819-822.
80. Hagerty T, Klein P. Fat partitioning of lidocaine in tumescent liposuction. Ann Plast Surg. 1999;42:372-375.
81. Hardy SP, Ortiz-Colberg R, Poquette MA. Re: Fat partitioning of lidocaine in tumescent liposuction. Ann Plast Surg. 1999;43:574.
82. Gumucio CA, Bennie JB, Fernando B, Young VL, Roa N, Kraemer BA. Plasma lidocaine levels during augmentation mammoplasty and suction-assisted lipectomy. Plast Reconstr Surg. 1989;84:624-627.
83. Facchinetti A, Sparacino G, Cobelli C. Reconstruction of glucose in plasma from interstitial fluid continuous glucose monitoring data: Role of sensor calibration. J Diabetes Sci Technol. 2007;1:617-623.
84. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003;52:2790-2794.
85. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003;26: 2405-2409.
86. Hahn RG. Influence of the fluid balance on the cortisol and glucose responses to transurethral prostatic resection. Acta Anaesthesiol Scand. 1989;33:638-641.
87. Piros D, Fagerström T, Collins JW, Hahn RG. Glucose as a marker of fluid absorption in bipolar transurethral surgery. Anesth Analg. 2009;109:1850-1855.
88. Thomas JT, Chawla A, Thomas J. Serum glucose as a predictor of fluid absorption during transurethral bipolar prostatic surgery. Indian J Urol. 2010;26:466-468.
89. El-Ali KM, Gourlay T. Assessment of the risk of systemic fat mobilization and fat embolism as a consequence of liposuction: Ex vivo study. Plast Reconstr Surg. 2006;117:2269-2276.